TALS   $26.9  -90.18% Market Open

Talaris Therapeutics Inc
Total Cash 152.25M
totalCashPerShare 35.603
EBITDA -68.16M
Total Debt 1.03M
quickRatio 15.024
currentRatio 15.414
Total Revenue
debtToEquity 0.691
Revenue/Share
ROA -0.22813
ROE -0.41637
grossProfits
freeCashflow -27.52M
operatingCashflow -58.88M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -34.91M
forwardPE
floatShares 4.21M
sharesOutstanding 42.81M
sharesShort 340.10K
sharesShortPriorMonth 478.54K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.78%
Short Ratio help_outline 4.01%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 34.884
Price To Book help_outline 0.08
earningsQuarterlyGrowth
netIncomeToCommon -74.77M
trailingEps -1.74%
forwardEps -0.34%
enterpriseToEbitda 0.51
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2023
institutionsCount 86
lastUpdated Dec. 21, 2023, 7:28 p.m.